In thyroid cancer, TCSCs were further found to interfere with CD8+ T cell activity by upregulating inhibitory immune checkpoint receptors on the surface with CD8+ T cells, which is an important pathway for them to escape immune surveillance (14). This evidence concerns the gene CD8A and thyroid cancer.